Cyntellect Laser-Based Assay System Shows Potential for RNAi Compound Transfection | GenomeWeb

In trying to overcome RNAi’s delivery hurdle, many researchers are experimenting with viral vectors, liposomal formulations, hydrodynamic administration, and the like. But one privately held company, Cyntellect, has taken a different tack: the company’s platform uses lasers to temporarily permeablize cells for transfection. Although the technology is not commercially available, Cyntellect has already signed several deals to pilot test the technology for interested parties, one of which is to purchase a prototype of the platform this year.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.